NSRI
GRCL

New Silk Road Investment’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

New Silk Road Investment’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$650K – 15
2021
Q2 		$650K Hold
50,000
– – 0.34% 14
2021
Q1 		$770K Buy
+50,000
New +$770K 0.52% 9